The Global Metabolism Drugs Market Growth Accelerated By Increasing Incidence Of Metabolic Disorders

 

METABOLISM DRUGS MARKET
Metabolism Drugs Market

Metabolism drugs are used for the treatment of metabolic disorders like diabetes and obesity that have become highly prevalent worldwide. Metabolism drugs help regulate blood sugar levels, aid weight loss, lower cholesterol, and balance hormones. Increasing lifestyle changes such as sedentary jobs, junk food consumption, and reduced physical activity have fueled the risk of metabolic diseases.

The global Metabolism Drugs Market is estimated to be valued at Us$ 9410.88 Mn in 2024 and is expected to exhibit a CAGR Of 2.3% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:


Increasing demand for combination therapy drugs is one of the key trends driving the growth of the metabolism drugs market. Combination therapy involves the use of two or more drugs with distinct mechanisms of action for better management of complex diseases like diabetes. Combining medications provide enhanced therapeutic effects, improves treatment outcomes and compliance. For instance, medications combining drugs such as metformin and another oral antidiabetic drug or insulin are widely used for diabetes management. The synergistic effects of combination drugs help achieve better glycemic control and control progression of diabetes with reduced drug dosage and side effects. Thus, growing preference for fixed-dose combination drugs is anticipated to boost the metabolism drugs market during the forecast period.

Segment Analysis


The global metabolism drugs market is segmented on the basis of drug class, therapeutic area, distribution channel and region. Based on drug class, the market is segmented into anti-diabetics drugs, anti-obesity drugs, corticosteroids, respiratory drugs, thyroid hormone therapy, others. Among these, anti-diabetics drugs segment dominates the market and is expected to continue its dominance during the forecast period. This is majorly due to the increasing prevalence of diabetes across the globe and rising sales of glucose lowering drugs used in treatment of diabetes.

Key Takeaways


The Global Metabolism Drugs Market Size is expected to witness high growth during the forecast period of 2024 to 2031. The global Metabolism Drugs Market is estimated to be valued at US$ 9410.88 Mn in 2024 and is expected to exhibit a CAGR of 2.3% over the forecast period 2024 to 2031.

Regional analysis:

North America dominates the global metabolism drugs market and is expected to continue its dominance during the forecast period. This is attributed to the well-established healthcare infrastructure and growing prevalence of metabolic disorders in the region.

Key players:

Key players operating in the Metabolism Drugs Market are 3M, Automotive T, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, Eli Lilly and Company, AstraZeneca plc., Boehringer Ingelheim GmbH.

Get more insights on this topic :

https://www.insightprobing.com/the-global-metabolism-drugs-market-growth-is-projected-to-driven-by-increased-obesity-rates/

Check more trending articles on this topic:

https://techaxen.com/medicine-testing-services-in-the-us-ensuring-product-safety-and-compliance/

Comments

Popular posts from this blog

The Global Ebola Vaccine Market Is Estimated To Grow At Highest Pace Owing To Rising Ebola Cases

Aseptic Processing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Sterile Products

Growing Demand Accelerated By Enhanced Customer Support. Chatbots Are Intelligent Artificial Assistant Designed To Have Natural Conversations To Provide Support To Customer